US Broker Ratings

GH Research PLC (GHRS) Stock Analysis: A 92% Upside Potential in the Biotechnology Arena

GH Research PLC (NASDAQ: GHRS), a burgeoning player in the biotechnology sector, is capturing attention with its promising pipeline and impressive analyst ratings. Based in Dublin,..

KalVista Pharmaceuticals, Inc. (KALV) Stock Analysis: Exploring a 122% Potential Upside in the Biotech Space

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) is making waves in the biotechnology sector with its innovative approach to treating hereditary angioedema (HAE), a rare and potentially life-threatening..

Inventiva S.A. (IVA): Exploring a 140% Upside Potential with Strong Analyst Consensus

For investors scouting the biotechnology landscape, Inventiva S.A. (NASDAQ: IVA) presents a compelling opportunity. Based in Daix, France, this clinical-stage biopharmaceutical company is focused on developing..

Delcath Systems, Inc. (DCTH) Investor Outlook: Exploring a Potential 118.74% Upside in the Healthcare Sector

Delcath Systems, Inc. (NASDAQ: DCTH) is making waves in the healthcare sector with its innovative approach to treating liver cancers. With a market capitalization of $360.55..

Altimmune, Inc. (ALT) Stock Analysis: Exploring the 318% Potential Upside

Altimmune, Inc. (NASDAQ: ALT) stands out in the biotechnology sector with an intriguing proposition for investors, driven by its innovative approach to tackling obesity and liver..

Butterfly Network, Inc. (BFLY) Stock Analysis: Potential Growth in the Healthcare Sector Despite Current Valuation Challenges

Butterfly Network, Inc. (NYSE: BFLY) is carving out a significant niche in the healthcare sector with its innovative ultrasound imaging solutions. Headquartered in Burlington, Massachusetts, Butterfly..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating a Challenging Market with Strategic Staffing Solutions

Cross Country Healthcare, Inc. (NASDAQ: CCRN) is a noteworthy player in the healthcare staffing industry, navigating a complex market landscape with a focus on talent management..

Tilray Brands, Inc. (TLRY) Stock Analysis: Exploring a 31.88% Potential Upside Amidst Industry Challenges

Tilray Brands, Inc. (NASDAQ: TLRY) presents a compelling case for investors within the dynamic healthcare sector, specifically in the niche of drug manufacturing specializing in cannabis..

Akso Health Group (AHG) Investor Outlook: Unpacking the 415% Revenue Surge in China’s Healthcare Market

For investors with an eye on the healthcare sector, Akso Health Group (NASDAQ: AHG), a burgeoning player in the medical distribution industry, is making waves with..

CorMedix Inc. (CRMD) Stock Analysis: Eyeing a 140% Upside in Biotech Innovation

CorMedix Inc. (NASDAQ: CRMD) stands at the forefront of the biotechnology sector, presenting a compelling investment opportunity with a substantial potential upside of 140.47%. This biopharmaceutical..

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Exploring a Potential 94.68% Upside

Eton Pharmaceuticals, Inc. (ETON), a notable player in the healthcare sector specializing in the development and commercialization of treatments for rare diseases, presents a compelling case..

Evolus, Inc. (EOLS) Stock Analysis: Is a 256% Upside on the Horizon?

Investors with an eye on the healthcare sector, particularly the specialty drug manufacturing niche, might want to give Evolus, Inc. (NASDAQ: EOLS) a closer look. With..

Gyre Therapeutics, Inc. (GYRE) Stock Analysis: Biotechnology Firm with a Potential 133% Upside Gathers Investor Attention

Gyre Therapeutics, Inc. (NASDAQ: GYRE), a San Diego-based biotechnology firm, has quickly become a topic of interest for investors seeking high-growth opportunities in the healthcare sector...

Xeris Biopharma Holdings, Inc. (XERS) Stock Analysis: Unveiling a 50% Potential Upside in Biotech

Xeris Biopharma Holdings, Inc. (XERS) is making waves in the biotechnology sector with its focus on chronic endocrine and neurological disorders. With a market capitalization of..

Stoke Therapeutics, Inc. (STOK) Stock Analysis: Unpacking a 26.79% Upside Potential in Biotech

Stoke Therapeutics, Inc. (NASDAQ: STOK) has been capturing attention in the biotechnology sector with its innovative approach to tackling severe genetic diseases. As a U.S.-based biopharmaceutical..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: A Potential 111% Upside in Biotechnology

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company, presents a compelling opportunity for investors eyeing significant returns in the healthcare sector. With a market capitalization..

Bioventus Inc. (BVS) Stock Analysis: Unlocking an 87% Potential Upside in the Healthcare Sector

Bioventus Inc. (BVS), a prominent player in the medical device industry, presents an intriguing proposition for investors eyeing the healthcare sector. Headquartered in Durham, North Carolina,..

Sionna Therapeutics, Inc. (SION) Stock Analysis: Promising Upside with 20.33% Potential in the Biotech Sector

Sionna Therapeutics, Inc. (NASDAQ: SION) is catching the attention of investors with its intriguing position in the biotechnology sector. As a clinical-stage biopharmaceutical company based in..

Cullinan Therapeutics, Inc. (CGEM)

⚠️ No article content returned.

..

Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: Exploring a 109% Potential Upside in Gene Therapy

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is a burgeoning player in the biotechnology sector, specializing in the development of gene therapies for rare and often life-threatening diseases...

US Broker Ratings

US Broker Ratings

FTSE 100

Funds